Photodegradation and photostability studies of bendroflumethiazide in pharmaceutical formulations and urine samples by micellar liquid chromatography

LC-GC North America

Volumn 23, Issue 2, 2005, Pages 182-199

  Ruiz Angel M J ^a,b   Gil Agusti M T ^a   Esteve Romero, J S ^a   Carda Broch, S ^a  

^a UNIVERSITAT JAUME I   (Spain)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BENDROFLUMETHIAZIDE; HYDROFLUMETHIAZIDE;

ARTICLE; CHEMICAL ANALYSIS; CONTAMINATION; CONTROLLED STUDY; DRUG ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; MICELLAR LIQUID CHROMATOGRAPHY; PHOTODEGRADATION; TOXICITY; URINALYSIS;

EID: 13944249456     PISSN: 15275949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. A.H. Hikal, J. Liquid Chromatogr. 9(13), 2937-2943 (1986).
2. IOC, The Olympic Movement Anti-Doping Code, IOC, 2000 (http://www.olympic.org/ioc/e/org/medcom/medcom_antidopage_e.html).
3. R. Frontini and J.B. Mielck, J. Liquid Chromatogr. 15(14), 2519-2528 (1992).
4. R. Frontini and J.B. Mielck, Eur. J. Pharm. Biopharm. 44, 85-88 (1997).
5. M.E. Mohamed and H.Y. Aboul-Enein, Anal. Lett. 18, 2591-2603 (1985).
6. C. Van Kerchove, R. Bontemps, and A. Shoenmakers, J. Pharm. Pharmacol. 34, 420-424 (1982).
7. M.I. Maguregui, R.M. Jimenez, and R.M. Alonso, J. Chromatogr. Sci. 36, 516-522 (1998).
8. N.W. Smith and M.B. Evans, Chromatographia 41, 197-203 (1995).
9. M. Schafer-Korting and E. Mutschler, Eur. J. Clin. Pharmacol. 21, 315-323 (1982).
10. S.P. Agarwal and J. Nwaiwu, J. Chromatogr. 351, 383-387 (1986).
11. S. Carda-Broch, J.S. Esteve-Romero, and M.C. García-Alvarez-Coque, Analyst 123, 301-306 (1998).
12. R.M. Smith, G.A. Murilla and T.G. Hurdley, J. Chromatogr. 384, 259-278 (1987).
13. B. Beerman, M. Groschinsky-Grind, and B. Lindström, Eur. J. Clin. Pharmacol. 10, 293 (1976).
14. C. Fagerlund, P. Hartvig, and B. Lindström, J. Chromatogr. 168, 107-116 (1979).
15. J.A. Mollica, C.R. Rehm, and J. B. Smith, J. Pharm. Sci. 58, 635-636 (1969).
16. J.A. Mollica et al., J. Pharm. Sci. 60, 1380-1384 (1971).
17. A.R. Barnes and S. Nash, J. Clin. Pharm. Ther. 19, 89-93 (1994).
18. A.R. Barnes and S. Nash, Int. J. Pharm. Ther. 94, 231-234 (1993).
19. S. Carda-Broch, J. Esteve-Romero, and M.C. García-Álvarez- Coque, J. Pharm. Biomed. Anal. 23, 803-817 (2000).
20. S. Carda-Broch et al., Analyst 127, 29-34 (2002).
21. M.C. García-Álvarez-Coque and S. Carda-Broch, J. Chromatogr., B 736, 1-18 (1999).
22. M.J. Ruiz-Angel et al., J. Chromatogr., A 947, 31-45 (2002).
23. S. Carda-Broch et al., J Chromatogr., A 893, 321-337 (2000).
24. V. Ulvi and H. Keski-Hynnilä, J. Pharm. Biomed. Anal. 12, 917-922 (1994).
25. V. Ulvi, J. Pharm. Biomed. Anal. 17, 77-82 (1998).
26. E. Selvaag and P. Thune, Photodermatol. Photoimmunol. Photomed. 12, 79-83 (1996).
27. D. Thieme et al., J. Chromatogr., B 757, 49-57 (2001).
28. J.J. Alastair and M.D. Wood, N. Engl. J. Med. 339, 387-395 (1998).